Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 months ago

Possible Interaction: Glucose and Human Insulin Aspart

Research Papers that Mention the Interaction

Mean fasting PG was significantly lower for IDegAsp vs BIAsp 30 (treatment difference (TD): -0.99 mmol/l (95% confidence interval: -1.68; 0.29)) and AF vs BIAsp 30 (TD: -0.88 mmol/l (-1.58; -0.18)).
European journal of endocrinology  •  2012  |  View Paper
The (median) time to maximum SG was 25 min shorter for IAsp compared with HI (P=0.048).
Diabetic medicine : a journal of the British Diabetic Association  •  2005  |  View Paper
Within-person day-to-day variation in plasma glucose was lower with insulin detemir/insulin aspart than with NPH insulin/regular human insulin (SD: 2.88 vs 3.12 mmol/l; p<0.001).
Diabetologia  •  2004  |  View Paper
Glucose areas under the curve above baseline were significantly lower with insulin aspart (180-min area, 7.1 mg.
Diabetes care  •  2003  |  View Paper
OBJECTIVE Both rapid-acting insulin analogs, insulin aspart and lispro, attenuate prandial glucose excursion compared with human soluble insulin.
Diabetes care  •  2002  |  View Paper
Reduction in fasting plasma glucose was statistically significantly greater for IDegAsp than for BIAsp 30 (estimated treatment difference, IDegAsp-BIAsp 30: -1.6 mmol/L, 95% confidence interval: -2.4 to -0.8).
Journal of diabetes investigation  •  2017  |  View Paper
▴ In healthy individuals undergoing euglycaemic glucose clamp testing, glucose infusion rates were higher and reached maximum concentrations significantly earlier after insulin aspart than after human insulin.
Drugs  •  2012  |  View Paper